إعلان
إعلان

VTYX

VTYX logo

Ventyx Biosciences, Inc. Common Stock

13.72
USD
برعاية
+3.67
+36.55%
٠٧ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

13.73

+0.01
+0.09%

تقارير أرباح VTYX

النسبة الإيجابية المفاجئة

VTYX تفوق 12 من 17 آخر التقديرات.

71%

التقرير التالي

بيانات التقرير القادم
٠٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.37
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+15.63%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-9.76%

Ventyx Biosciences, Inc. Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, VTYX reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 30.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -5.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an زيادة of 15.63% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Ventyx Biosciences, Inc. Common Stock reported EPS of -$0.32, beating estimates by 30.09%, and revenue of $0.00, 0% as expectations.
The stock price moved down -5.29%, changed from $9.26 before the earnings release to $8.77 the day after.
The next earning report is scheduled for ٠٤ فبراير ٢٠٢٦.
Based on 10 المحللين, Ventyx Biosciences, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان